Compound Library (JHCCL, Baltimore, MD), such that the final PAD collection contains 2,080 drugs.
Galleria mellonella survival assay. G. mellonella were injected (5 µl aliquots) with 5x10 6 cfu of live CA-MRSA USA300 bacteria using a Hamilton syringe. Following bacterial cells, cefuroxime, ticlopidine and their combination (dissolved in water) were administered in 2 µl aliquots. Five control groups were used, including untreated larvae, larvae injected with saline, water and their combination, and larvae injected with saline and cefuroxime, ticlopidine and their combination. For each treatment, a group of at least 10 larvae were injected. Experiments were repeated 3 independent times with different batches of larvae and the results averaged. Larvae were left at room temperature and scored as dead or alive every 24 hrs for 14 days.
Interaction studies of ticlopidine with antibiotics of known mechanism. 8x8 matrices of ticlopidine in combination with various known antibiotics were tested for interactions against CA-MRSA USA300 using the same conditions as screening. FIC indexes were calculated to evaluate the interactions. NaCl and stored at -80 o C overnight. Frozen cell pellets were thawed in an equal volume of lysis buffer (50 mM Tris pH = 8, 10 mM MgCl 2 , 1 mM EDTA, 100 µg mL -1 DNase, 100 µg mL -1
RNase, 1 protease inhibitor cocktail tablet (Roche)), and lysed with a One Shot Cell Disruptor (Constant Systems Ltd.). Lysate was clarified by centrifugation (40 000 x g, 15 minutes).
Membranes were recovered from the supernatant of the previous step by ultracentrifugation (111 000 x g, 60 min) and resuspended in Reaction Buffer (50 mM Tris pH = 8, 10 mM MgCl 2 , 1 mM EDTA) to a final concentration of approximately 60 mg membrane protein/mL (as determined by the Bradford method).
Generation of a tarH conditional deletion strain. To create a xylose-dependent tarH conditional strain (EBII244), the xylose repressor encoded by xylR and the xylA promoter were first subcloned from pSWEET-tarD into the MfeI and BamHI sites of pCL55 to generate pCL55-tarD. tarH was amplified from pG164-tarH (EBII10) with primers # (5' -GGGCTTAATTAAGGAAGGTCTACAAATGAACGTTTCGGTAAACA -3') and # (5' -GGGCGGATCCGTTTAAACTCGAGCGGCCGCTTATTTAATAACGA -3') and cloned into the PacI and BamHI sites of pCL55-tarD to generate pCL55-tarH. All inserts were verified by sequencing (MOBIX, McMaster University, Hamilton, ON). pCL55-tarH was then transformed into EBII4 using standard electroporation methods and selected for on MHA containing chloramphenicol (15ug/mL) and kanamycin (20ug/mL). Integration of pCL55-tarH into the geh locus of EBII4 was confirmed by PCR. This tarH single integrant strain was then passaged three times on MHA containing 5% sucrose, 2% xylose and erythromycin (10ug/mL). The resultant conditional tarH deletion strain (EBII244) was confirmed by PCR and tested for xylosedependence by streaking on MHA plates with or without 2% xylose.
Phage susceptibility. Strain S. aureus RN450 was grown to exponential phase in the presence of compounds, plated and incubated with bacteriophage 11. Plates were incubated for 24 hours at 37°C.
Peptidoglycan isolation and lysozyme susceptibility. Cell wall samples from ticlopidinetreated cells and CA-MRSAUSA300 ∆tarO were treated with 48% hydrofluoric acid at 4°C for 24 hours. Peptidoglycan was harvested by centrifugation at 30,000 rpm for 30 minutes and washed twice with water. Peptidoglycan was incubated in 80mM NaOH at 37 °C for 3 h, spun and resuspended in 80 mM sodium phosphate buffer/0.85% NaCl (pH 6.5) to similar optical densities. Peptidoglycan was digested with 300 µg/mL chicken egg white lysozyme (SigmaAldrich). The decrease in the absorbance at OD600 nm was monitored at 30-min intervals for 6 hrs using a Sunrise plate reader (Tecan).
TarA and MnaA expression and purification. Expression and purification of TarA and MnaA as previously described (6) .
In vitro TarA inhibition assay. TarA was assayed in 50 uL reactions containing 50 mM tris (pH Plates were incubated for 24 hours at 37°C.
Supplementary Figure 7.
Peptidoglycan derived from ticlopidine-treated cells is more susceptible to degradation by lysozyme. Shown is the hydrolysis of purified PG from CA-MRSA USA300 (circles), CA-MRSA USA300 ∆tarO (squares) and ticlopidine (200 µg/mL)-treated CA-MRSA USA300 (triangles) followed by monitoring the decrease in OD 600nm over time. Supplementary Table 6 . FIC determination of cefoxitin in combination with ß-lactams of highaffinity for PBP2 (*) and of low affinity for PBP2 against CA-MRSA USA300. Fold change represents the decrease in the MIC of the ß-lactam in the presence of cefoxitin.
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